association (references)

References for: association

Full identifier: http://purl.org/np/RAS58vy1cAZNlnmngw0-gjvhtMXtf2CbshN_Lk_tih3bg#association

Nanopublication	Part	Subject	Predicate	Object	Published By	Published On
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#type type	http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement	Leoni Bücken	2021-06-27T18:38:29.445Z
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/2000/01/rdf-schema#label label	paliperidone is an atypical antipsychotic agent indicated for treatment of schizophrenia 1 1 adults efficacy was established in three 6 week trials and one maintenance trial 14 1 adolescents ages 12 to 17 efficacy was established in one 6 week trial 14 1 treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and or antidepressants 1 2 efficacy was established in two 6 week trials in adult patients 14 2 paliperidone extended release tablets are indicated for the treatment of schizophrenia see clinical studies 14 1 the efficacy of paliperidone in schizophrenia was established in three 6 week trials in adults and one 6 week trial in adolescents as well as one maintenance trial in adults paliperidone extended release tablets are indicated for the treatment of schizoaffective disorder as monotherapy and an adjunct to mood stabilizers and or antidepressant therapy see clinical studies 14 2 the efficacy of paliperidone in schizoaffective disorder was established in two 6 week trials in adults	Leoni Bücken	2021-06-27T18:38:29.445Z
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#object object	http://purl.obolibrary.org/obo/DOID_5419 DOID_5419	Leoni Bücken	2021-06-27T18:38:29.445Z
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate	https://w3id.org/biolink/vocab/treats treats	Leoni Bücken	2021-06-27T18:38:29.445Z
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject	https://identifiers.org/drugbank:DB01267 drugbank:DB01267	Leoni Bücken	2021-06-27T18:38:29.445Z
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/association_type association_type	https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation	Leoni Bücken	2021-06-27T18:38:29.445Z
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/provided_by provided_by	https://w3id.org/um/NeuroDKG NeuroDKG	Leoni Bücken	2021-06-27T18:38:29.445Z
http://purl.org/np/RAS58vy1cA... RAS58vy1cA	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/relation relation	https://schema.org/TreatmentIndication TreatmentIndication	Leoni Bücken	2021-06-27T18:38:29.445Z